Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1981 1
1984 1
1986 1
1987 1
1988 1
1989 1
1990 3
1991 3
1992 3
1993 5
1994 6
1995 5
1996 5
1997 5
1998 7
1999 6
2000 5
2001 1
2002 6
2003 12
2004 8
2005 8
2006 15
2007 12
2008 10
2009 14
2010 35
2011 42
2012 49
2013 38
2014 45
2015 33
2016 31
2017 25
2018 42
2019 35
2020 49
2021 55
2022 30
2023 54
2024 43

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

650 results

Results by year

Filters applied: . Clear all
Page 1
Progesterone Receptor Signaling Mechanisms.
Grimm SL, Hartig SM, Edwards DP. Grimm SL, et al. J Mol Biol. 2016 Sep 25;428(19):3831-49. doi: 10.1016/j.jmb.2016.06.020. Epub 2016 Jul 2. J Mol Biol. 2016. PMID: 27380738 Review.
Circadian dysfunction induces NAFLD-related human liver cancer in a mouse model.
Padilla J, Osman NM, Bissig-Choisat B, Grimm SL, Qin X, Major AM, Yang L, Lopez-Terrada D, Coarfa C, Li F, Bissig KD, Moore DD, Fu L. Padilla J, et al. Among authors: grimm sl. J Hepatol. 2024 Feb;80(2):282-292. doi: 10.1016/j.jhep.2023.10.018. Epub 2023 Oct 27. J Hepatol. 2024. PMID: 37890720
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, Abrey LE, DeAngelis LM, Omuro A. Morris PG, et al. Among authors: grimm s. J Clin Oncol. 2013 Nov 1;31(31):3971-9. doi: 10.1200/JCO.2013.50.4910. Epub 2013 Oct 7. J Clin Oncol. 2013. PMID: 24101038 Free PMC article. Clinical Trial.
Introduction.
Grimm S. Grimm S. Adv Exp Med Biol. 2014;818:1-8. doi: 10.1007/978-1-4471-6458-6_1. Adv Exp Med Biol. 2014. PMID: 25001529 No abstract available.
Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer.
Ahn S, Park JH, Grimm SL, Piyarathna DWB, Samanta T, Putluri V, Mezquita D, Fuqua SAW, Putluri N, Coarfa C, Kaipparettu BA. Ahn S, et al. Among authors: grimm sl. Cancer Res. 2024 Jan 16;84(2):291-304. doi: 10.1158/0008-5472.CAN-23-0184. Cancer Res. 2024. PMID: 37906431 Free PMC article.
Anaplastic astrocytoma.
Grimm SA, Chamberlain MC. Grimm SA, et al. CNS Oncol. 2016 Jul;5(3):145-57. doi: 10.2217/cns-2016-0002. Epub 2016 May 27. CNS Oncol. 2016. PMID: 27230974 Free PMC article. Review.
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.
Fares J, Ahmed AU, Ulasov IV, Sonabend AM, Miska J, Lee-Chang C, Balyasnikova IV, Chandler JP, Portnow J, Tate MC, Kumthekar P, Lukas RV, Grimm SA, Adams AK, Hébert CD, Strong TV, Amidei C, Arrieta VA, Zannikou M, Horbinski C, Zhang H, Burdett KB, Curiel DT, Sachdev S, Aboody KS, Stupp R, Lesniak MS. Fares J, et al. Among authors: grimm sa. Lancet Oncol. 2021 Aug;22(8):1103-1114. doi: 10.1016/S1470-2045(21)00245-X. Epub 2021 Jun 29. Lancet Oncol. 2021. PMID: 34214495 Free PMC article. Clinical Trial.
Meningiomas.
Grimm S, Raizer JJ. Grimm S, et al. Curr Treat Options Neurol. 2008 Jul;10(4):315-20. doi: 10.1007/s11940-008-0034-9. Curr Treat Options Neurol. 2008. PMID: 18579018
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics.
Kumthekar PU, Avram MJ, Lassman AB, Lin NU, Lee E, Grimm SA, Schwartz M, Bell Burdett KL, Lukas RV, Dixit K, Perron I, Zhang H, Gradishar WJ, Pentsova EI, Jeyapalan S, Groves MD, Melisko M, Raizer JJ. Kumthekar PU, et al. Among authors: grimm sa. Neuro Oncol. 2023 Mar 14;25(3):557-565. doi: 10.1093/neuonc/noac195. Neuro Oncol. 2023. PMID: 35948282 Free PMC article. Clinical Trial.
650 results